,MLLT3

Wenbo Shi1, Tongyangzi Zhang1, Li Zhang1

  • 1Department of Pulmonary and Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

Drug development research
|November 6, 2024
PubMed
概括

过度表达MLLT3与肺腺癌 (LUAD) 进展,转移和生存率低下有关. 抑制MLLT3抑制了LUAD细胞的生长和入侵,这表明MLLT3是肺癌的潜在治疗标.